Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRize Circular Regulatory News (CIRC)

Share Price Information for Rize Circular (CIRC)

Share Price is delayed by 15 minutes
Get Live Data
472.40    0.00 (0.00%)
Bid:
473.90
Ask:
479.25
Spread: 5.35 (1.129%)
Market Cap: -
CIRC Live PriceLast checked at - London Stock Exchange

Intraday Rize Circular Share Chart

Board Change

4 Dec 2012 13:22

RNS Number : 6997S
Circle Holdings PLC
04 December 2012
 

FOR IMMEDIATE RELEASE 4 dECEMBER 2012

Circle Holdings plc

(the "Company" or "Circle")

 

Board Changes

 

CEO Ali Parsa Relinquishes Executive Role

Board Appoints Steve Melton as Interim CEO

 

 

Circle Holdings plc (LSE: CIRC), the vehicle which enables financial institutions to invest in Circle Health, the healthcare enterprise co-owned by the largest partnership of doctors, nurses and healthcare professionals in the UK, announces that Ali Parsa has today stepped down as Chief Executive and that Steve Melton has, on an interim basis, assumed the position of Chief Executive. Ali Parsa will remain on the Board of Circle as Founder and a Non-Executive Director.

 

"Ali has been instrumental in forming the entrepreneurial vision and early development of the Company," said Michael Kirkwood, Chairman of Circle Holdings. "Ali has been a pioneer developing a business model which empowers doctors, nurses and healthcare professionals to redefine UK healthcare delivery for the benefit of their patients. Following on from the successful establishment of its business model which delivers patient value in both private and NHS healthcare settings, Ali and the Board have agreed that now is the appropriate time for him to assume a Non-Executive role. As many will know, Ali has a number of external interests and now will be able to spend more time fulfilling his passion for social entrepreneurship."

 

Steve is currently Circle's Head of Mobilisation, having joined Circle in February 2008. He has been responsible for a multitude of significant achievements made by the Company which includes leading the successful opening of the Bath and Reading hospitals in March 2010 and August 2012 respectively, and the initiation of the Nottingham Treatment Centre contract where Circle has demonstrated a successful track record for delivery. He also led the final phases of bidding, negotiation, and mobilisation of the Hinchingbrooke contract.

 

The Board of Circle will now begin a recruitment process to select a high calibre successor with candidates from both inside and outside the Company. The Company does not expect to make any additional structural changes or executive leadership changes in the near future.

 

Commenting on the Board changes, Ali Parsa said: "I am immensely proud of what has been achieved by Circle since it was founded. I wish to step down from my executive leadership role so that I have the time I need for other projects that now require some of my focus. I look forward to assisting Steve and Circle in the implementation of its business plans as a Non-Executive Director. Circle has a very talented executive team supported by a dedicated and focused workforce. The Company is exceptionally well positioned strategically and I expect it to be very successful in the future."

 

Commenting further on the Board changes, Michael Kirkwood, Chairman of Circle Holdings, said: "The Board would like to thank Ali for the considerable momentum and value he has contributed to Circle over the past 8 years in establishing the Company as a new and successful leader in the industry. It is testament to his vision and ambition that Circle has grown into such a vibrant company and with the rest of the Board, I look forward to continuing to work with Ali as he assumes a new Non-Executive role. As an interim measure, Steve Melton will assume the role of Chief Executive. At Circle, Steve has demonstrated considerable success at both an operational and leadership level across all areas of the business. I am therefore very confident that under his stewardship, and with our strong overall team, the Company is well placed to continue with its focus on excellent patient care and entrepreneurial vision to deliver on the next phase in its development and thereby deliver to the expectations of all our shareholders."

 

Information required to be disclosed under AIM Rules:

 

Details of Steve Melton's current and previous directorships in the past five years are set out below.

 

Current directorships:

NATIONS HEALTHCARE WEST LONDON 2006 LIMITED

NATIONS HEALTHCARE LIMITED

NATIONS HEALTHCARE (NOTTINGHAM) LIMITED

NATIONS HEALTHCARE (BURTON) LIMITED

CIRCLE HEALTH LIMITED

CIRCLE HOSPITAL (BATH) LTD

CIRCLE HINCHINGBROOKE LIMITED

CIRCLE HOSPITAL (READING) LIMITED

CIRCLE INTERNATIONAL PLC

CIRCLE BIRMINGHAM LIMITED

CIRCLE PARTNERSHIP (UK) LIMITED

 

Previous directorships:

NATIONS HEALTHCARE (NORTH BRADFORD) LIMITED

SCOTTISH COURAGE BREWING LIMITED

 

Mr Melton, aged 50, holds no Ordinary Shares and no share options in Circle Holdings plc. Mr Melton has an interest of approximately 1.5 per cent. in the Circle Partnership Limited.

 

There is no further information in connection with the appointment of Mr Melton to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

 

 

For further information, please contact:

 

Circle Holdings plc +44 (0)20 7034 5258

Michael Kirkwood, Chairman

Christina Robinson, Communications Manager

 

 

Numis Securities +44 (0)20 7260 1000

Michael Meade, Nominated Adviser

Alex Ham, Corporate Broking

 

 

M:Communications +44 (0)20 7920 2333

Mary-Jane Elliott

Sarah Macleod

Claire Dickinson

 

About Circle

 

The Company's principal asset is its holding in Circle Health Limited ("Circle Health"), an employee co-owned healthcare provider. Circle Health is 50.1 per cent. owned by the Company and 49.9 per cent. owned by the Circle Partnership Limited which is 100 per cent. beneficially owned by the group's clinicians and employees.

 

Circle's objective is to redefine secondary healthcare delivery in the UK. It benefits from a unique operating model which has been successfully applied and proven, whereby clinicians are empowered to achieve high levels of patient care and efficiency, though co-ownership and active participation in managing operations.

 

The Company is a Jersey incorporated company and the rights of shareholders may be different from the rights of shareholders in a UK incorporated company.

 

For more information please visit www.circleholdingsplc.com and www.circlepartnership.co.uk 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUSUORUAAURAA
Date   Source Headline
7th Sep 20164:40 pmRNSSecond Price Monitoring Extn
7th Sep 20164:35 pmRNSPrice Monitoring Extension
25th Aug 20167:00 amRNSHalf Year Results for period ended 30 June 2016
16th Aug 20167:00 amRNSCircle selected preferred bidder for MSK service
29th Jun 20167:00 amRNSDevelopment and Management Agreement in China
9th Jun 20164:41 pmRNSHolding(s) in Company
8th Jun 20165:39 pmRNSHolding(s) in Company
8th Jun 20163:07 pmRNSHolding(s) in Company
6th Jun 20161:09 pmRNSConversion of Convertible Shares
18th May 201612:27 pmRNSResult of AGM
17th May 20164:40 pmRNSSecond Price Monitoring Extn
17th May 20164:35 pmRNSPrice Monitoring Extension
26th Apr 20163:03 pmRNSNotice of AGM
1st Apr 20163:58 pmRNSNotification of major interest in shares
30th Mar 20167:00 amRNSFull Year 2015 Audited Results
14th Mar 20164:40 pmRNSSecond Price Monitoring Extn
14th Mar 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
29th Jan 20164:40 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20167:00 amRNSMovement in Share Price
12th Oct 20157:00 amRNSOperator agreement with CircleHealth for Harley St
12th Oct 20157:00 amRNSStatement regarding new cancer centre
27th Aug 20157:00 amRNSHalf Yearly Report
21st Jul 20154:40 pmRNSSecond Price Monitoring Extn
21st Jul 20154:35 pmRNSPrice Monitoring Extension
26th Jun 20154:40 pmRNSSecond Price Monitoring Extn
26th Jun 20154:35 pmRNSPrice Monitoring Extension
23rd Jun 20157:00 amRNSGrant of Options to Executive Directors
20th May 20151:59 pmRNSResult of AGM
13th May 20154:35 pmRNSPrice Monitoring Extension
5th May 20152:53 pmRNSPOSTING OF ANNUAL REPORT AND AGM
28th Apr 20153:55 pmRNSNotification of major interest in shares
28th Apr 20153:22 pmRNSVoting Rights Announcement
28th Apr 201512:30 pmRNSNotification of major interest in shares
27th Apr 20158:04 amRNSVoting Rights Announcement
24th Apr 20152:37 pmRNSNotification of major interest in shares
24th Apr 20152:15 pmRNSNotification of major interest in shares
16th Apr 201510:20 amRNSNotification of major interest in shares
14th Apr 20157:00 amRNSNotification of major interest in shares
19th Mar 20157:00 amRNSAnnual Financial Report
9th Jan 20157:00 amRNSStatement regarding Hinchingbrooke
6th Jan 20152:27 pmRNSNotification of Major Interest in Shares
12th Dec 20142:52 pmRNSNotification of Major Interest in Shares
11th Dec 20148:30 amRNSNotification of Major Interest in Shares
11th Dec 20148:30 amRNSNotification of Major Interest in Shares
9th Dec 20144:39 pmRNSNotifications of Major Interests in Shares
5th Dec 20147:00 amRNSProject Reset Completed
29th Oct 201412:39 pmRNSApproval of Project Reset by Shareholders
22nd Oct 20149:39 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.